[1]
Harshidha, D. et al. 2022. A Pilot Study of Omalizumab to Treat Severe Allergic Asthma in South Indian Population. Journal of Drug Delivery and Therapeutics. 12, 6-S (Dec. 2022), 21–23. DOI:https://doi.org/10.22270/jddt.v12i6-S.5855.